HAPILA and their distribution partner Transo-Pharm Handels GmbH have joined forces years ago in order to provide Estriol to more and more customers with high quality Estriol made in Germany.
The collaboration entered into a new phase when we decided to expand capacity at the Hapila site in order to adequately supply the Estriol market.
Consequently we made the decision to join forces at the CPhI Exhibition in Frankfurt and to integrate Hapila into the Transo-Pharm booth.
A few recent updates on Estriol:
Looking forward to see you at CPHI in Frankfurt.
Transo-Pharm Handels-GmbH and HAPILA GmbH are determined to deepen their relationship and have therefore jointly decided to expand the production capacities at the HAPILA site in Gera, mainly to meet the increasing demand for the active ingredient Estriol Micronized.
The planning for the construction and installation work started in 2020.
The new facility is expected to be completed in 2022.
For more information please download attachements (German or English available).